Title of article
Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia
Author/Authors
Steven P. Govek، نويسنده , , Céline Bonnefous، نويسنده , , John H. Hutchinson، نويسنده , , Theodore Kamenecka، نويسنده , , Jeffrey McQuiston، نويسنده , , Richard Pracitto، نويسنده , , Lucy X. Zhao، نويسنده , , Michael F. Gardner، نويسنده , , Joyce K. James، نويسنده , , Lorrie P. Daggett، نويسنده , , Blake A. Rowe، نويسنده , , Herve Schaffhauser، نويسنده , , Linda J. Bristow، نويسنده , , Una C. Campbell، نويسنده , , Dana E. Rodriguez، نويسنده , , Jean-Michel Vernier، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2005
Pages
5
From page
4068
To page
4072
Abstract
Metabotropic glutamate receptor 2 (mGluR2) has been implicated in a variety of CNS disorders, including schizophrenia. Disclosed herein is the development of a new series of allosteric potentiators of mGluR2. Structure–activity relationship studies in conjunction with pharmacokinetic data led to the discovery of indole 5, which is active in an animal model for schizophrenia.
Keywords
metabotropic glutamate receptor , Schizophrenia , Allosteric potentiator , mGluR2 , mGlu2
Journal title
Bioorganic & Medicinal Chemistry Letters
Serial Year
2005
Journal title
Bioorganic & Medicinal Chemistry Letters
Record number
795935
Link To Document